Massachusetts 2023-2024 Regular Session

Massachusetts Senate Bill S1384 Compare Versions

Only one version of the bill is available at this time.

Old	New	Differences
1	1	1 of 1
2	2	SENATE DOCKET, NO. 1765 FILED ON: 1/19/2023
3	3	SENATE . . . . . . . . . . . . . . No. 1384
4	4	The Commonwealth of Massachusetts
5	5	_________________
6	6	PRESENTED BY:
7	7	John F. Keenan
8	8	_________________
9	9	To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General
10	10	Court assembled:
11	11	The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill:
12	12	An Act relative to the prescription monitoring program.
13	13	_______________
14	14	PETITION OF:
15	15	NAME:DISTRICT/ADDRESS :John F. KeenanNorfolk and Plymouth 1 of 2
16	16	SENATE DOCKET, NO. 1765 FILED ON: 1/19/2023
17	17	SENATE . . . . . . . . . . . . . . No. 1384
18	18	By Mr. Keenan, a petition (accompanied by bill, Senate, No. 1384) of John F. Keenan for
19	19	legislation relative to the prescription monitoring program. Public Health.
20	20	[SIMILAR MATTER FILED IN PREVIOUS SESSION
21	21	SEE SENATE, NO. 1451 OF 2021-2022.]
22	22	The Commonwealth of Massachusetts
23	23	_______________
24	24	In the One Hundred and Ninety-Third General Court
25	25	(2023-2024)
26	26	_______________
27	27	An Act relative to the prescription monitoring program.
28	28	Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority
29	29	of the same, as follows:
30	30	1 SECTION 1. Section 24A of Chapter 94C of the General Laws, as appearing in the 2020
31	31	2Official Edition, is hereby amended by inserting after subsection (c) the following new
32	32	3subsection:-
33	33	4 (c½) The department shall establish, by rule or regulation, a process by which to include
34	34	5information about the administration of opioid maintenance treatment in the prescription
35	35	6monitoring program, when the inclusion of such information does not conflict with state or
36	36	7federal privacy rules. The purpose of this subsection shall be to ensure that licensed professionals
37	37	8authorized to prescribe controlled substances receive information, through utilization of the
38	38	9prescription monitoring program, about an individual patient’s participation in opioid 2 of 2
39	39	10maintenance treatment prior to issuing a new prescription for an opioid substance other than the
40	40	11substance used for opioid maintenance treatment.
41	41	12 SECTION 2. Section 18 of chapter 111E of the General Laws, is hereby amended by
42	42	13inserting after subsection (a) the following new subsection:-
43	43	14 (a½) For each facility that is an opioid treatment program, as defined under 42 CFR Part
44	44	158, the facility shall present to each individual entering treatment a form that allows the individual
45	45	16to consent to the release of information, through the prescription monitoring program, about the
46	46	17administration of opioid maintenance treatment at the facility. Said consent form shall be
47	47	18accompanied by information clearly explaining that such consent is not required but is
48	48	19encouraged to improve coordination of services; and by information on how the individual may
49	49	20complete and return the form to the facility or to the department of public health if they elect to
50	50	21give such consent. A record of the individual’s election relative to this form shall be maintained
51	51	22by the facility as part of the record of treatment required by this section. The same form and
52	52	23information shall be presented to the individual upon their discharge from the facility.